Worcester HIV Vaccine
伍斯特艾滋疫苗公司
伍斯特艾滋疫苗公司
Biotech
Drug Discovery and Development
4th Floor, One Innovation Drive
Worcester
MA
Worcester HIV Vaccine is a biotechnology company formed in 2018 to accelerate clinical development of the preventive HIV vaccine candidate using a polyvalent DNA-prime/protein-boost approach developed at the University of Massachusetts Medical School.
伍斯特艾滋疫苗公司(WHV) 是一家2018年创立的生物技术公司,旨在加快推动根据美国麻省大学医学院发明的多价DNA初免/蛋白质加强免疫策略而设计的预防性艾滋疫苗的临床发展。
Vaccine,HIV infection,Polyvalent DNA-prime/protein-boost,Clinical development
